Your browser doesn't support javascript.
loading
Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer.
Golfmann, Kristina; Meder, Lydia; Koker, Mirjam; Volz, Caroline; Borchmann, Sven; Tharun, Lars; Dietlein, Felix; Malchers, Florian; Florin, Alexandra; Büttner, Reinhard; Rosen, Neal; Rodrik-Outmezguine, Vanessa; Hallek, Michael; Ullrich, Roland T.
Afiliação
  • Golfmann K; Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Meder L; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch Straße 21, 50931, Cologne, Germany.
  • Koker M; Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Volz C; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch Straße 21, 50931, Cologne, Germany.
  • Borchmann S; Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Tharun L; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch Straße 21, 50931, Cologne, Germany.
  • Dietlein F; Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Malchers F; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch Straße 21, 50931, Cologne, Germany.
  • Florin A; Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Büttner R; Center for Molecular Medicine Cologne, University of Cologne, Robert-Koch Straße 21, 50931, Cologne, Germany.
  • Rosen N; German Hodgkin Study Group, Department I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Rodrik-Outmezguine V; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, 50931, Cologne, Germany.
  • Hallek M; Institute for Pathology, University Hospital Cologne, Kerpener Straße 62, 50937, Cologne, Germany.
  • Ullrich RT; Else Kröner Forschungskolleg Clonal Evolution in Cancer, University Hospital Cologne, 50931, Cologne, Germany.
Oncogene ; 37(42): 5682-5693, 2018 10.
Article em En | MEDLINE | ID: mdl-29970903
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores da Angiogênese / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores da Angiogênese / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido